HIGHLIGHTS
- who: Agnese Paderi and collaborators from the Clinical Oncology Unit, Careggi University Hospital, Largo Brambilla, Florence, Italy have published the research work: Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors, in the Journal: (JOURNAL)
- what: Within this study, the authors aimed to describe toxicities in a real-world cohort of mRCC patients and their potential association with treatment response.
- how: This study was conducted in accordance with the World Medical Association Declaration of Helsinki and independently reviewed and approved by the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.